- Home
- VHC vs ANEB Comparison
VHC vs ANEB Comparison
Compare VHC & ANEB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VHC
- ANEB
- Stock Information
- Founded
- VHC 2005
- ANEB 2020
- Country
- VHC United States
- ANEB United States
- Employees
- VHC N/A
- ANEB N/A
- Industry
- VHC Multi-Sector Companies
- ANEB Biotechnology: Pharmaceutical Preparations
- Sector
- VHC Miscellaneous
- ANEB Health Care
- Exchange
- VHC Nasdaq
- ANEB Nasdaq
- Market Cap
- VHC 33.6M
- ANEB 36.7M
- IPO Year
- VHC 1999
- ANEB 2021
- Fundamental
- Price
- VHC $9.04
- ANEB $1.26
- Analyst Decision
- VHC
- ANEB Buy
- Analyst Count
- VHC 0
- ANEB 1
- Target Price
- VHC N/A
- ANEB $8.00
- AVG Volume (30 Days)
- VHC 5.7K
- ANEB 12.6K
- Earning Date
- VHC 03-14-2025
- ANEB 02-14-2025
- Dividend Yield
- VHC N/A
- ANEB N/A
- EPS Growth
- VHC N/A
- ANEB N/A
- EPS
- VHC N/A
- ANEB N/A
- Revenue
- VHC $5,000.00
- ANEB N/A
- Revenue This Year
- VHC N/A
- ANEB N/A
- Revenue Next Year
- VHC N/A
- ANEB N/A
- P/E Ratio
- VHC N/A
- ANEB N/A
- Revenue Growth
- VHC N/A
- ANEB N/A
- 52 Week Low
- VHC $3.55
- ANEB $0.80
- 52 Week High
- VHC $9.69
- ANEB $3.30
- Technical
- Relative Strength Index (RSI)
- VHC 59.67
- ANEB 37.49
- Support Level
- VHC $8.90
- ANEB $1.45
- Resistance Level
- VHC $9.34
- ANEB $1.56
- Average True Range (ATR)
- VHC 0.35
- ANEB 0.15
- MACD
- VHC -0.11
- ANEB -0.02
- Stochastic Oscillator
- VHC 63.64
- ANEB 2.00
About VHC VirnetX Holding Corp
VirnetX Holding Corp is engaged in the business of commercializing a portfolio of patents. It is an Internet security software and technology company with patented technology for secure communications. The company's software and technology solutions, including its Secure Domain Name Registry and Technology, VirnetX One, War Room, VirnetX Matrix, and GABRIEL Connection Technology, are designed to be device and location-independent, and enable a secure real-time communication environment for all types of enterprise applications, services, and critical infrastructures.
About ANEB Anebulo Pharmaceuticals Inc.
Anebulo Pharmaceuticals Inc is a clinical-stage biotechnology company, developing novel solutions for people suffering from cannabinoid overdose and substance addiction. The product candidate, ANEB-001, is intended to reverse the negative effects of cannabinoid overdose within 1 hour of administration. The signs and symptoms of cannabinoid overdose range from profound sedation to anxiety and panic to psychosis with hallucinations.